Analysis of clinical data revealed a significant correlation between high GPR56 levels and poor outcome in acute myeloid leukemia, ovarian cancer, and colorectal cancer (CRC) (10, 11, 12, 13, 14, 15). The gene discussed is ADGRG1; the disease is colorectal cancer.